P. Perros, L. Hegedüs, L. Bartalena et al. Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement. Orphanet. J. Rare Dis. 12, 72 (2017). https://doi.org/10.1186/s13023-017-0625-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

L. Bartalena, E. Piantanida, D. Gallo et al. Epidemiology, natural history, risk factors, and prevention of Graves’ orbitopathy. Front. Endocrinol. 11, 615993 (2020). https://doi.org/10.3389/fendo.2020.615993

Article  Google Scholar 

J. Längericht, I. Krämer, G.J. Kahaly, Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application. Ther. Adv. Endocrinol. Metab. 11, 2042018820958335 (2020). https://doi.org/10.1177/2042018820958335

Article  CAS  PubMed  PubMed Central  Google Scholar 

H. Zhang, J. Fan, J. Qu et al. Predictive markers for anti-inflammatory treatment response in thyroid eye disease. Front. Endocrinol. 14, 12925192023 (2023). https://doi.org/10.3389/fendo.2023.1292519

Article  Google Scholar 

G. Vannucchi, D. Covelli, I. Campi et al. The therapeutic outcome to intravenous steroid therapy for active Graves’ orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor. Eur. J. Endocrinol. 170, 55–61 (2014). https://doi.org/10.1530/eje-13-0611

Article  CAS  PubMed  Google Scholar 

M. Leo, T. Mautone, I. Ionni et al. Variables affecting the long-term outcome of graves orbitopathy following high-dose intravenous glucocorticoid pulse therapy in patients not treated with orbital radiotherapy. Endocr. Pract. 22, 1177–1186 (2016). https://doi.org/10.4158/e161376.Or

Article  PubMed  Google Scholar 

Y. Li, B. Luo, J. Zhang et al. Clinical relevance of serum immunoglobulin G4 in glucocorticoid therapy of Graves’ ophthalmopathy. Clin. Endocrinol. 95, 657–667 (2021). https://doi.org/10.1111/cen.14493

Article  CAS  Google Scholar 

M. Siomkajło, Ł. Mizera, D. Szymczak et al. Effect of systemic steroid therapy in Graves’ orbitopathy on regulatory T cells and Th17/Treg ratio. J. Endocrinol. Invest. 44, 2475–2484 (2021). https://doi.org/10.1007/s40618-021-01565-w

Article  CAS  PubMed  Google Scholar 

N. Xu, Y. Cui, D. Fu et al. Tear inflammatory cytokines and ocular surface changes in patients with active thyroid eye disease treated with high-dose intravenous glucocorticoids. J. Endocrinol. Invest. 43, 901–910 (2020). https://doi.org/10.1007/s40618-019-01174-8

Article  CAS  PubMed  Google Scholar 

W. Choi, Y. Li, Y.S. Ji et al. Oxidative stress markers in tears of patients with Graves’ orbitopathy and their correlation with clinical activity score. BMC Ophthalmol. 18, 1–7 (2018). https://doi.org/10.1186/s12886-018-0969-x

Article  CAS  Google Scholar 

H. Hu, X.Q. Xu, L. Chen et al. Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues. Endocrine 70, 372–379 (2020). https://doi.org/10.1007/s12020-020-02367-5

Article  CAS  PubMed  Google Scholar 

L. Zhai, B. Luo, H. Wu et al. Prediction of treatment response to intravenous glucocorticoid in patients with thyroid-associated ophthalmopathy using T2 mapping and T2 IDEAL. Eur. J. Radiol. 142, 109839 (2021). https://doi.org/10.1016/j.ejrad.2021.109839

Article  PubMed  Google Scholar 

L. Bartalena, G. Veronesi, G.E. Krassas et al. Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy? J. Endocrinol. Invest. 40, 547–553 (2017). https://doi.org/10.1007/s40618-017-0608-z

Article  CAS  PubMed  Google Scholar 

S. Inoue, M. Kawashima, R. Arita et al. Investigation of meibomian gland function and dry eye disease in patients with Graves’ ophthalmopathy. J. Clin. Med. 9, 2814 (2020). https://doi.org/10.3390/jcm9092814

Article  PubMed  PubMed Central  Google Scholar 

J. Park, J. Kim, H. Lee et al. Functional and structural evaluation of the meibomian gland using LipiView interferometer in thyroid eye disease. Can. J. Ophthalmol. 53, 373–379 (2018). https://doi.org/10.1016/j.jcjo.2017.11.006

Article  PubMed  Google Scholar 

Y.S. Kim, A.Y. Kwak, S.Y. Lee et al. Meibomian gland dysfunction in Graves’ orbitopathy. Can. J. Ophthalmol. 50, 278–282 (2015). https://doi.org/10.1016/j.jcjo.2015.05.012

Article  PubMed  Google Scholar 

M. Jamshidian Tehrani, Z. Mahdizad, A. Kasaei et al. Early macular and peripapillary vasculature dropout in active thyroid eye disease. Graefes Arch. Clin. Exp. Ophthalmol. 257, 2533–2540 (2019). https://doi.org/10.1007/s00417-019-04442-8

Article  PubMed  Google Scholar 

Y. Wu, Y. Tu, L. Bao et al. Reduced retinal microvascular density related to activity status and serum antibodies in patients with Graves’ ophthalmopathy. Curr. Eye Res. 45, 576–584 (2020). https://doi.org/10.1080/02713683.2019.1675177

Article  PubMed  Google Scholar 

N. Mihailovic, L. Lahme, F. Rosenberger et al. Altered retinal perfusion in patients with inactive graves ophthalmopathy using optical coherence tomography angiography. Endocr. Pract. 26, 312–317 (2020). https://doi.org/10.4158/ep-2019-0328

Article  PubMed  Google Scholar 

K. Fazil, G. Ozturk Karabulut, Z. Alkin, Evaluation of choroidal thickness and retinal vessel density in patients with inactive Graves’ orbitopathy. Photodiagnosis Photodyn. Ther. 32, 101898 (2020). https://doi.org/10.1016/j.pdpdt.2020.101898

Article  PubMed  Google Scholar 

M. Trindade, J. Castro de Vasconcelos, G. Ayub et al. Ocular manifestations and neuropathy in type 2 diabetes patients with Charcot arthropathy. Front. Endocrinol. 12, 585823 (2021). https://doi.org/10.3389/fendo.2021.585823

Article  Google Scholar 

A. Tomlinson, A.J. Bron, D.R. Korb et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest. Ophthalmol. Vis. Sci. 52, 2006–2049 (2011). https://doi.org/10.1167/iovs.10-6997f

Article  PubMed  PubMed Central  Google Scholar 

P. Xiao, Z. Luo, Y. Deng et al. An automated and multiparametric algorithm for objective analysis of meibography images. Quant. Imaging Med. Surg. 11, 1586–1599 (2021). https://doi.org/10.21037/qims-20-611

Article  PubMed  PubMed Central  Google Scholar 

Y. Deng, Q. Wang, Z. Luo et al. Quantitative analysis of morphological and functional features in Meibography for meibomian gland dysfunction: diagnosis and grading. eClinicalMedicine 40, 101132 (2021). https://doi.org/10.1016/j.eclinm.2021.101132

Article  PubMed  PubMed Central  Google Scholar 

Y. Wang, S. Zhang, Y. Zhang et al. A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy. BMC Endocr. Disord. 18, 13 (2018). https://doi.org/10.1186/s12902-018-0240-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.T. Wang, M. Vidal-Rohr, A. Muntz et al. Systemic risk factors of dry eye disease subtypes: a New Zealand cross-sectional study. Ocul. Surf. 18, 374–380 (2020). https://doi.org/10.1016/j.jtos.2020.04.003

Article  PubMed  Google Scholar 

C.Y. Wang, R.W. Ho, P.C. Fang et al. The function and morphology of meibomian glands in patients with thyroid eye disease: a preliminary study. BMC Ophthalmol. 18, 90 (2018). https://doi.org/10.1186/s12886-018-0763-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

V. Satitpitakul, T. Rattanaphong, V. Pruksakorn, Meibomian glands dropout in patients with inactive thyroid related orbitopathy. PLoS ONE 16, e0250617 (2021). https://doi.org/10.1371/journal.pone.0250617

Article  CAS  PubMed  PubMed Central  Google Scholar 

B.J. Fenner, G.S.W. Tan, A.C.S. Tan et al. Identification of imaging features that determine quality and repeatability of retinal capillary plexus density measurements in OCT angiography. Br. J. Ophthalmol. 102, 509–514 (2018). https://doi.org/10.1136/bjophthalmol-2017-310700

Article  PubMed